APA (7th ed.) Citation

RM, M., MLS, M., LAB, C., TG, N., VR, v. D., AP, S., . . . E, J. (2025). Phase II/III randomized immunogenicity and safety study of a Brazilian meningococcal serogroup B vaccine in children. Vaccine, 61, 127363. https://doi.org/10.1016/j.vaccine.2025.127363

Chicago Style (17th ed.) Citation

RM, Martins, Maia MLS, Camacho LAB, Noronha TG, von Doellinger VR, Santos AP, Figueira ES, Leal ML, and Jessouroun E. "Phase II/III Randomized Immunogenicity and Safety Study of a Brazilian Meningococcal Serogroup B Vaccine in Children." Vaccine 61 (2025): 127363. https://doi.org/10.1016/j.vaccine.2025.127363.

MLA (9th ed.) Citation

RM, Martins, et al. "Phase II/III Randomized Immunogenicity and Safety Study of a Brazilian Meningococcal Serogroup B Vaccine in Children." Vaccine, vol. 61, 2025, p. 127363, https://doi.org/10.1016/j.vaccine.2025.127363.